Timed tests in the clinical assessment of motor function in Parkinson's disease.

Acknowledgments

This paper was originally presented at the 7th Quadrennial Congress of the World Federation of Neuroscience Nurses in Amsterdam, Holland, July 1997. The author thanks Dr. H. Widner (Department of Clinical Neuroscience, Lund University Hospital, Sweden) for rewarding discussions. The author's own work has been supported by the Swedish Medical Research Council; the Medical Faculty, Lund University, Sweden; the Soderberg Foundation; and the King Gustaf V and Queen Victoria Foundation.

References

(1.) Agid Y, Ruberg M, Raisman R, et al: The biochemistry of Parkinson's disease. Pages 99-126 in: Parkinson's Disease, Stern G (editor). Chapman and Hall Medical, 1990.

(2.) Alexander GE, Crotchet MD: Functional architecture of basal ganglia circuits: Neural substances of parallel processing. Trends Neurosci 1990; 13(7): 266-271.

(3.) Baron MS, Vitek JL, Bakay RAE, et al: Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40(3): 355-366.

(4.) Boraud T, Tison E Gross C: Quantification of motor slowness in Parkinson's disease: Correlations between the tapping test and single joint ballistic movement parameters. Parkinsonism and Related Disorders 1997; 3(1): 47-50.

(5.) D'Costa DF, Abbott RJ, Pye IF, Millac PA: The apomorphine test in parkinsonian syndromes. J Neurol Neurosurg Psychiatry 1991; 54(10): 870-872.

(6.) Defer GL, Widner H, Marie RM, et al: Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999; 14(4): 572-584.

(7.) Duvoisin RC: The evaluation of extrapyramidal disease. Pages 313-325 in: Monoamines Noyaux gris Centraux et Syndrom de Parkinson, de Ajuriaguerra J, Gauthier G (editors). Georg & Cie, 1971.

(8.) Fahn S, Elton RL, members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. Pages 153-163 in: Recent Developments in Parkinson's Disease, Vol. 2, Fahn S, Marsden CD, Calne DB, Goldstein M (editors). MacMillan Healthcare Information, 1987.

(9.) Freeman JS, Cody FWJ, Schady W: The influence of external timing cues upon the rhythm of voluntary movements in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993; 56(10): 1078-1084.

(10.) Gasser T, Schwartz J, Arnold G, et al: Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol 1992; 49(11): 1131-1134.

(11.) Goetz CG, Stebbins GT, Chmura TA, et al: Teaching tape for the motor section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1995; 10(3): 263-266.

(12.) Hagell P, Widner H: Clinical rating of dyskinesias in Parkinson's disease: Use and reliability of a new rating scale. Mov Disord 1999; 14(3): 448-455.

(13.) Hagell P, Schrag A, Piccini P, et al: Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 1999; 122(Pt 6): 1121-1132.

(14.) Hauser RA, Freeman TB, Snow BJ, et al: Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease. Arch Neurol 1999; 56(2): 179-197.

(15.) Hilten JJ van, Wagemans EA, Ghafoerkhan SF, Laar T van: Movement characteristics in Parkinson's disease: Determination of dopaminergic responsiveness and threshold. Clin Neuropharmacol 1997; 20(5): 402-408.

(16.) Hoehn MM, Yahr M: Parkinsonism: Onset, progression and mortality. Neurology 1967; 17(5): 427-442.

(17.) Kumar R, Lozano AM, Kim YJ, et al: Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998; 51(3): 850-855.

(18.) Lang AE, Benabid AL, Koller WC, et al: The core assessment program for intracerebral transplantation. Mov Disord 1995; 10(4): 527-528.

(19.) Langston WJ, Widner H, Goetz CG, et al: Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992; 7(1): 2-13.

(20.) Lindvall O, Hagell P: Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 2000; in press.

(21.) Martinez-Martin P, Garcia Urra D, Balseiro Gomez J: Timed tests in Parkinson's disease evaluation. Mov Disord 1997; 12(1): 127-128.

(22.) McIntosh GC, Thaut MH, Rice RR, Miller RA: Stride frequency modulation in parkinsonian gait using rhythmic auditory stimulation. Ann Neurol 1994; 36(2): 316.

(23.) Remy P, Samson Y, Hantraye P, et al: Clinical correlates of [[sup.18]F] fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995; 38(4): 580-588.

(24.) Rossi P, Colosimo C, Moro E, et al: Acute challenge with apomorphine and levodopa in parkinsonism. Eur Neurol 2000; 43(2): 95-101.

(25.) Steg G, Ingvarsson PE, Johnels B, et al: Objective measurement of motor disability in Parkinson's disease. Acta Neurol Scand Suppl 1989; 126: 67-75.

(26.) Webster DD: Critical analysis of the disability in Parkinson's disease. Mod Treat 1968; 5(2): 257-282.

Questions or comments about this article may be directed to: Peter Hagell, BSc RN, Section of Restorative Neurology, Department of Clinical Neuroscience, Wallenberg Neuroscience Center, University Hospital, SE-221 85 Lund, Sweden. He is a movement disorder specialized nurse and doctoral student at the Department of Clinical Neuroscience, Lund University/University Hospital, Lund, Sweden.

Print Get the Mag Weekly Updates